These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22507576)

  • 1. How "unsafe" is propranolol when used in the treatment of infantile hemangioma?
    Prashanth GP
    J Am Acad Dermatol; 2012 May; 66(5):854-5; author reply 855-6. PubMed ID: 22507576
    [No Abstract]   [Full Text] [Related]  

  • 2. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.
    Farshchian M; Potts GA
    Australas J Dermatol; 2021 Nov; 62(4):e580-e581. PubMed ID: 34293182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol for infantile haemangiomas and neuroglycopenic seizures.
    Fusilli G; Merico G; Gurrado R; Rosa T; Acquafredda A; Cavallo L
    Acta Paediatr; 2010 Dec; 99(12):1756. PubMed ID: 20726852
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating hemangioma of infancy with beta-blockers: is there really a risk of hypotension?
    Janmohamed SR; de Laat PC; Madern GC; Dorresteijn EM; Jan Danser AH; Oranje AP
    J Am Acad Dermatol; 2012 Aug; 67(2):315-6; author reply 316-8. PubMed ID: 22794806
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence and nuances of propranolol safety.
    Püttgen KB
    Br J Dermatol; 2015 Feb; 172(2):319-20. PubMed ID: 25660680
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma.
    Greene AK
    Pediatr Dermatol; 2010; 27(3):322-3. PubMed ID: 20609168
    [No Abstract]   [Full Text] [Related]  

  • 8. Allergic contact dermatitis caused by topical propranolol in a 5-month-old baby.
    Bonifazi E; Milano A; Foti C
    Contact Dermatitis; 2014 Oct; 71(4):250-1. PubMed ID: 25231389
    [No Abstract]   [Full Text] [Related]  

  • 9. Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol.
    Meyer-Mueller C; Nicholson C; Polcari I; Boull C; Maguiness S
    Pediatr Dermatol; 2022 Mar; 39(2):255-259. PubMed ID: 35178750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkalemia complicating propranolol treatment of an infantile hemangioma.
    Pavlakovic H; Kietz S; Lauerer P; Zutt M; Lakomek M
    Pediatrics; 2010 Dec; 126(6):e1589-93. PubMed ID: 21115582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study of propranolol therapy in 109 infants with infantile hemangioma.
    Gan LQ; Ni SL; Tan Q; Wang H
    Pediatr Dermatol; 2013; 30(2):270-2. PubMed ID: 23252446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propranolol-induced Involution of Infantile Hemangioma.
    Gonzalez Martinez OG; Langer PD; Milman T
    Ophthalmology; 2023 Dec; 130(12):1359. PubMed ID: 37140507
    [No Abstract]   [Full Text] [Related]  

  • 15. Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma.
    Xerfan EMS; Andersen ML; Facina AS; Tufik S; Tomimori J
    World J Pediatr; 2020 Oct; 16(5):537-538. PubMed ID: 32016783
    [No Abstract]   [Full Text] [Related]  

  • 16. Generalized hypertrichosis in an infant after treatment with propranolol for infantile hemangioma.
    Mendez-Gallart R; García-Palacios M; Cortizo-Vazquez J; Bautista-Casasnovas A
    Indian J Dermatol Venereol Leprol; 2020; 86(3):311-313. PubMed ID: 32242868
    [No Abstract]   [Full Text] [Related]  

  • 17. Propranolol therapy for hemangiomas in infants with neonatal abstinence syndrome may produce intolerable side effects.
    Twist J; Chen A; Poffenberger P; Zinn Z
    Pediatr Dermatol; 2022 Mar; 39(2):273-274. PubMed ID: 35178766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of systemic propranolol treatment on physical growth of patients with infantile hemangiomas.
    Hu L; Zhou B; Huang H; Chang L; Qiu Y; Ma G; Chen H; Jin Y; Xu X; Lin X; Li W
    J Dermatol; 2016 Oct; 43(10):1160-1166. PubMed ID: 26945921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol induced hypoglycemia.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of propranolol therapy in 635 infants with infantile hemangioma.
    Luo Y; Zeng Y; Zhou B; Tang J
    Pediatr Dermatol; 2015; 32(1):151-2. PubMed ID: 24602103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.